Undiagnosed Disease

3

Review clinical trials related to Undiagnosed Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

UW Undiagnosed Genetic Diseases Program

The primary purpose of this study is to discover new disease genes for rare Mendelian disorders and its secondary purpose include diagnosing people with rare genetic disorders that have not been previously diagnosed through conventional clinical means, learning more about the pathobiology of genetic disorders, and developing novel diagnostic technologies and analytics. 500 participants with undiagnosed and suspected genetic disorders will be recruited.

Participants needed: 1,000
Trial details
Age: Up to 100Biological sex: AllType: ObservationalSponsor: University of Wisconsin, MadisonUpdated: May 29, 2026Locations: 1
Eligibility criteria

The applicant has a condition that remains undiagnosed despite thorough evaluati... [+5]

The applicant already has a diagnosis that explains the objective findings. [+3]

Status: Recruiting

Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community

This study is designed to utilize whole exome and whole genome sequencing techniques to identify underlying genetic causes for undiagnosed disorders in the Plain Communities, and to do population genetic studies looking at genetic drift and founder mutations in this unique population.

Participants needed: 300
Trial details
Age: Up to 100Biological sex: AllType: ObservationalSponsor: University of PittsburghUpdated: Mar 10, 2026Locations: 1
Eligibility criteria

Any person of Amish or Mennonite descent

Individuals who are not of Amish or Mennonite descent

Status: Recruiting

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaUpdated: Nov 19, 2024Locations: 1
Eligibility criteria

Age >= 18 years [+2]

none